The efficacy of "hybrid" percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: Insights from a US multicenter registry

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 4, 2014, Pages 646-651

  Christopoulos, Georgios ^a   Karmpaliotis, Dimitri ^b   Alaswad, Khaldoon ^c   Lombardi, William L ^d   Grantham, J Aaron ^e   Rangan, Bavana V ^a   Kotsia, Anna P ^a   Lembo, Nicholas ^b   Kandzari, David E ^b   Lee, James ^b   Kalynych, Anna ^b   Carlson, Harold ^b   Garcia, Santiago ^f   Banerjee, Subhash ^a   Thompson, Craig A ^g   Brilakis, Emmanouil S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Columbia University ^*  (United States)

^c Appleton Cardiology   (United States)

^d PeaceHealth Cardiology   (United States)

^e SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic total occlusion; in stent restenosis; percutaneous coronary intervention

Indexed keywords

ADULT; ALGORITHM; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC DISEASE; CHRONIC TOTAL CORONARY OCCLUSION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HUMAN; HYBRID PERCUTANEOUS CORONARY INTERVENTION; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; THERAPY EFFECT; TREATMENT RESPONSE; UNITED STATES; ADVERSE EFFECTS; AGED; CLINICAL PATHWAY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY OCCLUSION; CORONARY RESTENOSIS; DEVICES; HIGH VOLUME HOSPITAL; MIDDLE AGED; PROCEDURES; REGISTER; RISK FACTOR; STENT; TREATMENT OUTCOME;

AGED; ALGORITHMS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; CORONARY RESTENOSIS; CRITICAL PATHWAYS; FEMALE; HOSPITALS, HIGH-VOLUME; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; RISK FACTORS; STENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 84926188001     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25465     Document Type: Article

References (17)

1. Abbas AE, Brewington SD, Dixon SR, Boura J, Grines CL, O'Neill WW,. Success, safety, and mechanisms of failure of percutaneous coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery total occlusion. Am J Cardiol 2005; 95: 1462-1466.
2. Wilson W, Walsh S, Hanratty C, Strange J, Hill J, Sapontis J, Spratt J,. A novel approach to the management of occlusive in-stent restenosis (ISR). Eurointervention 2014; 9: 1285-1293.
3. Werner GS, Moehlis H, Tischer K,. Management of total restenotic occlusions. EuroIntervention 2009; 5 Suppl D: D79-D83.
4. Shah PB, Cutlip DE, Popma JJ, Kuntz RE, Ho KKL,. Incidence and predictors of late total occlusion following coronary stenting. Catheter Cardiovasc Interv 2003; 60: 344-351.
5. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R,. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010; 56: 1897-1907.
6. Abdel-karim AR, Lombardi WB, Banerjee S, Brilakis ES,. Contemporary outcomes of percutaneous intervention in chronic total coronary occlusions due to in-stent restenosis. Cardiovasc Revasc Med 2011; 12: 170-176.
7. Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, Lembo N, Pershad A, Kandzari DE, Buller CE, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv 2012; 5: 367-379.
8. Menon RV, Alaswad K, Lombardi W, Mishoe KL, Grantham JA, Marso SP, Rutherford B, Patel SM, Pokala NR, Rangan B, et al. The safety and efficacy of the "hybrid approach" to chronic total occlusions: insights from a contemporary multicenter US Registry. J Am Coll Cardiol 2013; 62 (18-S1): B119.
9. Morino Y, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv 2010; 3: 143-151.
10. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol 2009; 53: 919-928.
11. Hakim DA, Mintz GS, Sanidas E, Rusinova R, Weisz G, Leon MB, Moses JW, Stone GW, Maehara A,. Serial gray scale intravascular ultrasound findings in late drug-eluting stent restenosis. Am J Cardiol 2013; 111: 695-699.
12. Watabe H, Sato A, Hoshi T, Obara K, Kawamura R, Aonuma K,. Dislodged and mechanically distorted stent stuck within a previously implanted drug-eluting stent. Heart Vessels 2013; 28: 541-545.
13. Ohya H, Kyo E, Katoh O,. Successful bypass restenting across the struts of an occluded subintimal stent in chronic total occlusion using a retrograde approach. Catheter Cardiovasc Interv 2013; 82: E678-E683.
14. Papayannis A, Banerjee S, Brilakis ES,. Use of the crossboss catheter in coronary chronic total occlusion due to in-stent restenosis. Catheter Cardiovasc Interv 2012; 80: E30-E36.
15. Yang YM, Mehran R, Dangas G, Reyes A, Oin J, Stone GW, Leon MB, Moses JW,. Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions. Catheter Cardiovasc Interv 2004; 63: 462-468.
16. Brilakis ES, Lombardi WB, Banerjee S,. Use of the stingray (r) guidewire and the venture (r) catheter for crossing flush coronary chronic total occlusions due to in-stent restenosis. Catheter Cardiovasc Interv 2010; 76: 391-394.
17. Subinas A, Martin V, Hernandez F, Pan M, Teruel L, Suarez A, Moreu J, De La Torre JM, Vinhas H, Lozano I,. Percutaneous intervention in chronic total coronary occlusions due to in-stent restenosis: A multicenter registry. Eur Heart J 2013; 34.